Psychedelic pleasures: An affective understanding of the joys of tripping.
Frederik Bøhling
International Journal of Drug Policy November 1, 2017 DOI: 10.1016/j.drugpo.2017.07.017 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 100 |
| Population | Trip reports from an internet forum |
| Keywords | Affect theory Deleuze Pleasure Psychedelic drugs Trip reports |
| Key findings | Psychedelic drugs such as LSD and mushrooms, in combination with contextual factors, give rise to affective modifications of the drug user's capacities to feel, sense, and act. |
Abstract
This paper considers the pleasures of psychedelic drugs and proposes a Deleuzian understanding of drugged pleasures as affects. In spite of a large body of work on psychedelics, not least on their therapeutic potentials, the literature is almost completely devoid of discussions of the recreational practices and pleasures of entheogenic drugs. Yet, most people do not use psychedelics because of their curative powers, but because they are fun and enjoyable ways to alter the experience of reality. In the analytical part of the paper, I examine 100 trip reports from an internet forum in order to explore the pleasures of tripping. The analyses map out how drugs such as LSD and mushrooms - in combination with contextual factors such as other people, music and nature - give rise to a set of affective modifications of the drug user's capacities to feel, sense and act. In conclusion it is argued that taking seriously the large group of recreational users of hallucinogens is important not only because it broadens our understanding of how entheogenic drugs work in different bodies and settings, but also because it may enable a more productive and harm reductive transmission of knowledge between the scientific and recreational psychedelic communities.
Citations in the library
Cited by 24
- Microdosing psychedelics: Motivations, subjective effects and harm reduction International Journal of Drug Policy November 25, 2019
- Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature Current Topics in Behavioral Neurosciences 2022
- Pharmacosex: Reimagining sex, drugs and enhancement International Journal of Drug Policy November 24, 2020
- Psychedelics in the treatment of unipolar and bipolar depression International Journal of Bipolar Disorders July 5, 2022
- Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience Harm Reduction Journal July 24, 2022
and 19 more in the library
Cites 47
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
and 42 more in the library